ויפנד 200 מ"ג אבקה להזרקה
pfizer pharmaceuticals israel ltd - voriconazole 200 mg/vial - powder for solution for infusion - voriconazole - treatment of : - invasive aspergillosis fluconazole-resistant serious invasive candida infections (including c. krusei), - serious fungal infections caused by scedosporium spp. and fusarium spp.vfend should be administered primarily to immunocompromised patients with progressive possibly life-threatening infections. treatment of candidemia in non neutropenic patients.
ויפנד 200 מג אבקה להכנת תמיסה לעירוי
pfizer pfe pharmaceuticals israel ltd - voriconazole - אבקה להכנת תמיסה לאינפוזיה - voriconazole 200 mg/vial - voriconazole - voriconazole - treatment of :- invasive aspergillosis fluconazole-resistant serious invasive candida infections (including c. krusei) , - serious fungal infections caused by scedosporium spp. and fusarium spp.vfend should be administered primarily to immunocompromised patients with progressive possibly life-threatening infections. treatment of candidemia in non neutropenic patients.
ויפנד 40 מגמל אבקה להכנת תרחיף למתן דרך הפה
pfizer pfe pharmaceuticals israel ltd - voriconazole - אבקה להכנת תרחיף - voriconazole 40 mg/ml - voriconazole - voriconazole - treatment of : invasive aspergillosis, fluconazole-resistant serious invasive candida infections (including c. krusei) , serious fungal infections caused by scedosporium spp. and fusarium spp.vfend should be administered primarily to immunocompromised patients with progressive possibly life-threatening infections. treatment of candidemia in non neutropenic patients.
זולאייר 150 מג
novartis israel ltd - omalizumab - אבקה וממס להכנת תמיסה להזרקה - omalizumab 150 mg/dose - omalizumab - omalizumab - xolair is indicated for adults and adolescents (12 years of age and above) with moderate to severe persistent asthma who have a positive skin test or in vitro reactivity to a perennial aeroallergen and whose symptoms are inadequately controlled with inhaled corticosteroids. xolair has been shown to decrease the incidence of asthma exacerbations in these patients. safety and efficacy have not been established in other allergic conditions.
קרסמבה 100 מג כמוסות
pfizer pfe pharmaceuticals israel ltd - isavuconazole as sulfate - קפסולה קשיחה - isavuconazole as sulfate 100 mg - isavuconazole
קרסמבה 200 מג תוך ורידי
pfizer pfe pharmaceuticals israel ltd - isavuconazole as sulfate - אבקה להכנת תמיסה מרוכזת לעירוי - isavuconazole as sulfate 200 mg - isavuconazole